Therapeutic Prospects of Faricimab Injection for Patients Affected by Neovascular Age-Related Macular Degeneration
Clinical trial NCT07088445 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07088445
- Sponsor
- Hui Peng
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-09-01
- Primary completion
- 2026-06-30
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.